STAGE II CHRONIC LYMPHOCYTIC LEUKEMIA

Clinical trials for STAGE II CHRONIC LYMPHOCYTIC LEUKEMIA explained in plain language.

Never miss a new study

Get alerted when new STAGE II CHRONIC LYMPHOCYTIC LEUKEMIA trials appear

Sign up with your email to follow new studies for STAGE II CHRONIC LYMPHOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 2 Completed 1

New combo shows promise for Tough-to-Treat lymphomas

Disease control Completed

This study tested a combination of the drug lenalidomide with standard chemotherapy (EPOCH-R) in 55 people with aggressive B-cell lymphomas linked to the MYC gene. The goal was to find the safest dose and see if the combo helps keep cancer from growing. While the treatment may co…

Matched conditions: STAGE II CHRONIC LYMPHOCYTIC LEUKEMIA

Phase: PHASE1, PHASE2 • Sponsor: University of Chicago • Aim: Disease control

Last updated Apr 30, 2026 15:49 UTC

STAGE II CHRONIC LYMPHOCYTIC LEUKEMIA

Get alerted when new STAGE II CHRONIC LYMPHOCYTIC LEUKEMIA trials appear

New combo shows promise for Tough-to-Treat lymphomas